Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 3Other hematologic neoplasm 3Lymphoid 3Gastrointestinal 3Breast 3Other solid neoplasm 2Plasma cell 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Malignant Primary Pelvic Neoplasm 1

Interventions

Paclitaxel 74pembrolizumab 59Carboplatin 55Bevacizumab 55Specimen Handling 47Magnetic Resonance Spectroscopy 39Cisplatin 34olaparib 28Gemcitabine 26liposomal doxorubicin 24Biopsy 20Taxes 18Topotecan 17Nivolumab 17Doxorubicin 15Cyclophosphamide 15Immunoglobulin G 14Disulfides 14niraparib 12fludarabine 12Letrozole 12lenvatinib 11Surveys and Questionnaires 11atezolizumab 10Drug Therapy 10Brachytherapy 10durvalumab 9Radiotherapy 9Fulvestrant 9Docetaxel 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Exercise Test × Gynecologic × 90 days × Clear all
NCT05134142 2026-05-20

Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy

M.D. Anderson Cancer Center

Recruiting
200 enrolled
Gynecologic

Malignant Primary Pelvic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡